AstraZeneca's Imfinzi Gains Orphan Drug Status for SCLC science science / science 4 years ago 216 Views comments The FDA assigns an orphan drug designation to AstraZeneca's (AZN) Imfinzi for the treatment of small cell lung cancer, the most aggressive type of the ailment. Read more
Comments